Assertio Therapeutics Inc (USD)
ASRT
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 0.62 | 0.66 |
| 52-Wk Range | | |
| Last Close | 0.63 |
| Mkt Cap (m) | 51.59 |
| Dividend yield | - |
| ISIN | US04545L1070 |
| Volume | 458,948 |
| Exchange Venue | NAS |
Company Profile
Depomed Inc is a specialty pharmaceutical company focused on pain and other conditions and diseases of the central nervous system.
Key Information
| Price/Earning | - |
| Price/Book | 0.89 |
| Price/Sales | 0.20 |
| P/CF | 0.50 |
| Rev Growth (3 year avg) | -20.45 |
| EPS Growth (3 year avg) | - |
| Operating Margin % | -0.33 |
| Net Margin % | -94.64 |
| Return on Equity | -156.10 |
| Debt/Equity | 6.18 |
Documents
Prospectus
| en 05/09/2014 |
Annual Report
| en 31/12/2019 |
Financials
Income Statement
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Revenue (m) | 390 | 343 | 456 | 381 | 312 | 230 |
| Operating Income (m) | 237 | -25 | 25 | -4 | 64 | -1 |
| Net Income (m) | 132 | -76 | -89 | -102 | 37 | -217 |
| Basic EPS | 2.26 | -1.26 | -1.45 | -1.63 | 0.58 | -3.07 |
| Avg. Diluted Shares Outstanding (m) | 66 | 60 | 61 | 63 | 64 | 71 |
Balance Sheet
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Current Assets (m) | 618 | 309 | 306 | 231 | 208 | 104 |
| Non Current Assets (m) | 93 | 1,054 | 919 | 808 | 725 | 423 |
| Total Assets (m) | 711 | 1,363 | 1,225 | 1,039 | 933 | 527 |
| Current Liabilities (m) | 57 | 220 | 227 | 311 | 246 | 185 |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 364 | 315 | 251 | 170 | 220 | 58 |
Cash Flows
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Operating Cash Flows (m) | -56 | 144 | 66 | 62 | 72 | 90 |
| Capital Expenditure (m) | -1 | -27 | -3 | -1 | -6 | -1 |
Figures are quoted in USD unless stated otherwise
-
No change
$
0.63
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.